Q2 2021

Filed Sep 13, 2021 · 10-Q · 75 days after period end · 0001193125-21-271530

Q2 2021 · 10-Q

Revenue—

Net Income

-$6.37K

no prior Q2 2020 on file

EPS Diluted

$0.00

no prior Q2 2020 on file

Operating Income-$6,365—

Same quarter

no prior Q2 2020 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2021 · filed Sep 13, 2021 · 75 d after period end

Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR